Development of new copper-64 labeled rhodamine: a potential PET myocardial perfusion imaging agent
Abstract Background Myocardial perfusion imaging (MPI) is one of the most commonly performed investigations in nuclear medicine procedures. Due to the longer half-life of the emerging positron emitter copper-64 and its availability from low energy cyclotron, together with its well-known coordination...
Saved in:
Main Authors: | Norah AlHokbany (Author), Ibrahim AlJammaz (Author), Basem AlOtaibi (Author), Yousif AlMalki (Author), Bander AlJammaz (Author), Subhani M. Okarvi (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fast Fluorine-18 labeling and preclinical evaluation of novel Mucin1 and its Folate hybrid peptide conjugate for targeting breast carcinoma
by: I. Al Jammaz, et al.
Published: (2021) -
Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu]copper PET/CT
by: Kristoffer Kjærgaard, et al.
Published: (2020) -
Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging
by: Laure Badier, et al.
Published: (2024) -
Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents
by: Thines Kanagasundaram, et al.
Published: (2021) -
PET Imaging of the Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68
by: Hailey A. Houson, et al.
Published: (2022)